Eva Colás

ORCID: 0000-0002-4439-4254 · 12 papers in corpus
article 2026
Rethinking endometriosis recurrence: from clinical challenge to biological opportunity
·doi:10.1038/s44294-026-00128-9

Endometriosis postoperative recurrence remains a major clinical challenge and a poorly understood biological process, directly impacting long-term care. This narrative review integrates current knowledge on recurrence definitions, patterns,…

2023
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.
Cancers ·doi:10.3390/cancers15092605

Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on cancer antigen 125 (CA125) in high-grade EC are li…

preprint 2023
Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368609

Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368609.v1

Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure 2 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368606.v1

Supplementary Figure 2 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure 2 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368606

Supplementary Figure 2 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure 3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368603.v1

Supplementary Figure 3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure Legends 1-3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368600.v1

Supplementary Figure Legends 1-3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

preprint 2023
Supplementary Figure Legends 1-3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
·doi:10.1158/0008-5472.22368600

Supplementary Figure Legends 1-3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer

article 2020
External validation of putative biomarkers in eutopic endometrium of women with endometriosis using NanoString technology
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01965-6

PurposeTo combine different independent endometrial markers to classify the presence of endometriosis.MethodsEndometrial biopsies were obtained from 109 women with endometriosis as well as 110 control women. Nine candidate biomarkers indepe…

2019
EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer.
Cancers ·doi:10.3390/cancers11060839

Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for more than 89,000 deaths every year. Mortality is associated with presence of poor prognostic factors at diagnosis, i.e., diagnosis at an advan…

article 2016
Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers
·doi:10.1038/modpathol.2016.143

Endometrial cancer is the most common cancer of the female genital tract in developed countries. Although the majority of endometrial cancers are diagnosed at early stages and the 5-year overall survival is around 80%, early detection of th…